loading page

Managing allergic diseases in India require significant changes in health infrastructure
  • +2
  • Sujoy Khan,
  • Harpal Singh,
  • Esben Eller,
  • Ekansh Sharma,
  • Anirban Maitra
Sujoy Khan
Hull University Teaching Hospitals NHS Trust, Journal of Sketching Science
Author Profile
Harpal Singh
Astrazeneca Pharma India Ltd
Author Profile
Esben Eller
Thermo Fisher Scientific ImmunoDiagnostics Division
Author Profile
Ekansh Sharma
Thermo Fisher Scientific ImmunoDiagnostics Division
Author Profile
Anirban Maitra
Royal Manchester Children's Hospital
Author Profile

Abstract

The report by Krishna MT and colleagues reveals some of the challenges clinicians face in the management of allergic diseases in the Indian subcontinent, especially with lack of availability of adrenaline auto-injectors, accessibility to validated in-vitro diagnostics, standardized allergens for skin testing and allergen immunotherapy products.